Loïc Laplanche

485 total citations
14 papers, 174 citations indexed

About

Loïc Laplanche is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Loïc Laplanche has authored 14 papers receiving a total of 174 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Loïc Laplanche's work include Drug Transport and Resistance Mechanisms (3 papers), Computational Drug Discovery Methods (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Loïc Laplanche is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Computational Drug Discovery Methods (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). Loïc Laplanche collaborates with scholars based in Germany, United States and France. Loïc Laplanche's co-authors include Mario Mezler, Jens Sydor, G. Barbanel, J.M. Kamenka, Yutaro Hoshi, Masanori Tachikawa, Yasuo Uchida, Gert Fricker, Tetsuya Terasaki and Erica Barini and has published in prestigious journals such as Nature Reviews Drug Discovery, Pharmaceutical Research and Clinical Pharmacokinetics.

In The Last Decade

Loïc Laplanche

12 papers receiving 169 citations

Peers

Countries citing papers authored by Loïc Laplanche

Since Specialization

Citations

This map shows the geographic impact of Loïc Laplanche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loïc Laplanche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loïc Laplanche more than expected).

Fields of papers citing papers by Loïc Laplanche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loïc Laplanche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loïc Laplanche. The network helps show where Loïc Laplanche may publish in the future.

Co-authorship network of co-authors of Loïc Laplanche

This figure shows the co-authorship network connecting the top 25 collaborators of Loïc Laplanche. A scholar is included among the top collaborators of Loïc Laplanche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loïc Laplanche. Loïc Laplanche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Innovative Medicines Initiative public–private partnerships to enhance translational safety 2025 ·Nature Reviews Drug Discovery ·Salah‐Dine Chibout, Dominique Brees, (unknown), (unknown), Loïc Laplanche, Jonathan G. Moggs, Shashi K. Ramaiah, (unknown), Gunnar Schütz, (unknown), Thomas Steger‐Hartmann, Elisabetta Vaudano	1
2	Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn’s Disease and Ulcerative Colitis 2023 ·Clinical Pharmacokinetics ·Ana Victoria Ponce Bobadilla, Sven Stodtmann, (unknown), (unknown), Sven Mensing, Jonas Blaes, (unknown), Loïc Laplanche, (unknown), Nael M. Mostafa	4
3	Mucin-Protected Caco-2 Assay to Study Drug Permeation in the Presence of Complex Biorelevant Media 2022 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mirko Koziolek, (unknown), Loïc Laplanche, Mario Mezler	12
4	Collecting antibodies and large molecule biomarkers in mouse interstitial brain fluid: a comparison of microdialysis and cerebral open flow microperfusion 2021 ·mAbs ·(unknown), Erica Barini, Loïc Laplanche, (unknown), Mario Mezler	14
5	Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening 2020 ·Pharmaceutical Research ·Dong Ye, (unknown), Zhizhou Fang, (unknown), Loïc Laplanche, Mario Mezler	14
6	Quantitative Systems Toxicology Modeling To Address Key Safety Questions in Drug Development: A Focus of the TransQST Consortium 2020 ·Chemical Research in Toxicology ·(unknown), Ciarán Fisher, Laura I. Furlong, Loïc Laplanche, Brian Kevin Park, Carmen Pin, Julio Sáez-Rodríguez, Panuwat Trairatphisan	11
7	Novel, potent, selective, and brain penetrant phosphodiesterase 10A inhibitors 2018 ·Bioorganic & Medicinal Chemistry Letters ·Hervé Geneste, Karla Drescher, Clarissa G. Jakob, Loïc Laplanche, (unknown), Maricel Torrent	11
8	Quantitative Systems Pharmacology Model for Alzheimer Disease Indicates Targeting Sphingolipid Dysregulation as Potential Treatment Option 2018 ·CPT Pharmacometrics & Systems Pharmacology ·Diana Clausznitzer, César Pichardo‐Almarza, (unknown), J. van Bergeijk, (unknown), Loïc Laplanche, Neil Benson, Marjoleen Nijsen	19
9	A retrospective evaluation of species-specific sensitivity for neurological signs in toxicological studies: Is the dog more sensitive than the non-human primate? 2015 ·Toxicology Letters ·(unknown), Helga Lorenz, Loïc Laplanche, Thomas J. Hudzik, Heidrun Potschka, Katja Hempel	0
10	Genomic Knockout of Endogenous Canine P-Glycoprotein in Wild-Type, Human P-Glycoprotein and Human BCRP Transfected MDCKII Cell Lines by Zinc Finger Nucleases 2014 ·Pharmaceutical Research ·(unknown), (unknown), Loïc Laplanche, Yasuo Uchida, Yutaro Hoshi, Masanori Tachikawa, Tetsuya Terasaki, Jens Sydor, Gert Fricker	29
11	Evaluation of Organic Anion Transporting Polypeptide 1B1 and 1B3 Humanized Mice as a Translational Model to Study the Pharmacokinetics of Statins 2014 ·Drug Metabolism and Disposition ·Laurent Salphati, Xiaoyan Chu, Liangfu Chen, Bhagwat Prasad, Shannon Dallas, Raymond Evers, (unknown), Ethan G. Geier, Jonathan Kehler, Jeevan Kunta, Mario Mezler, Loïc Laplanche, Jodie Pang, Anja Rode, Matthew G. Soars, Jashvant D. Unadkat, Robert A.B. van Waterschoot, Jocelyn Yabut, Alfred H. Schinkel, Nico Scheer	30
12	High-Throughput Quantitative and Qualitative Analysis of Microsomal Incubations by Cocktail Analysis with an Ultraperformance Liquid Chromatography-Quadrupole Time-Of-Flight Mass Spectrometer System 2014 ·Bioanalysis ·Gisela Backfisch, (unknown), (unknown), (unknown), Jens Sydor, Loïc Laplanche, Michael Schulz	12
13	Hydroxyl radicals release in rat striatum involves metabotropic glutamate receptors 2003 ·Brain Research Bulletin ·Loïc Laplanche	3
14	The novel non-competitive N-methyl-d-aspartate antagonist gacyclidine blocks the glutamate-induced release of hydroxyl radicals in the striatum under conditions in which dizocilpine does not. A microdialysis study in rats 2000 ·Neuroscience Letters ·Loïc Laplanche, J.M. Kamenka, G. Barbanel	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact